-Acre-scale seed production planned in spring 2022 -First winter PHA Camelina planting expected in fall 2022 -Research program to produce...
JERSEY CITY, N.J., March 08, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome...
Application website is now open for the 2022 Scholarship ProgramFor the 2022-2023 academic year, the scholarship program has expanded to...
Exclusive extension of research discovery collaboration with Mass General Hospital (MGH)Focus of the program: development of novel oral SIK inhibitors...
MINNEAPOLIS, March 08, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for...
FREDERICK, Md., March 08, 2022 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company that specializes...
The companies have begun the Collaboration with a joint pre-clinical study and are expecting its results potentially to deepen the...
UCB’s Digital Care Solutions for Myasthenia Gravis to be Built on the BrightInsight PlatformSAN JOSE, Calif., March 08, 2022 (GLOBE...
Conference Call and Webcast Scheduled for March 14, 2022, 4:30 pm ET NEW YORK, NY, March 08, 2022 (GLOBE NEWSWIRE)...
BioNTech and Regeneron plan to jointly conduct clinical trials evaluating FixVac candidate BNT116 in combination with Libtayo for the treatment...
Sanofi recognized by S&P as one of the most sustainability-committed companies Paris, March 8, 2022. Sanofi was today recognized as...
The Company Ranked 65th of More Than 1,000 Companies AssessedCORAL GABLES, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals,...
BATON ROUGE, La., March 08, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
LONDON, March 08, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell...
WILMETTE, Ill., March 08, 2022 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing...
STUART, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink: GSAC), a development stage company...
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock...
SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage...
RALEIGH, N.C., March 08, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers...
Phase 3 OVAL trial enrolled 409 patients globally at centers in the United States, Europe, Israel, and JapanTop-line data from...
